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It is fully established that in the genesis of
mammary carcinomata several factors play a
role. Usually these factors are divided into 3
groups: (1) viral factors, (2) hormonal factors,
(3) genetic factors. Environmental factors
also are of importance, but usually these
factors have an indirect influence via the
endocrine system.
As has so often occurred in the history of
cancer research, the first and fundamental
observations have been made by clinicians.
This is also the case with the clinical observa-
tion of patients with mammary carcinoma.
The role ofthe ovary was first clearly demon-
strated in Scotland by Beatson in 1896.
The older clinicians were often confronted
with the fact that mammary tumours were
often more frequent in certain families than
one would expect from the overall observa-
tion. Thefamous, andoften citedexample, is
the Broca family. Broca was a well known
French surgeon who published his family tree
in 1866, which shows an extraordinary fre-
quency of mammary carcinoma over 4
generations. One striking fact that has
frequently been observed is that in such
families the age at which the cancer appeared
was earlier in subsequent generations than in
the preceding ones. Since Broca's publica-
tion many family histories have been reported
in which breast cancer was abnormally
frequent.
Great interest in the possibility of breast
cancer as a familial disease was aroused by
observations in mice at the beginning of the
century that in certain colonies more animals
died with mammary cancer than in others.
At that time the laws of Mendel were redis-
covered and therefore everyone was con-
vinced that breast cancer was a hereditary
disease which followed Mendelian rules. In
conffict with these laws, it was also seen that
the predisposition for mammary cancer in
mice was more often dependent upon the
mother than the father. This problem was
insoluble at that time. Inbred strains of
miceindispensable fortheseinvestigationshad
to be developed.
The observations of the experimental
workers aroused new interest of the clinicians
into this problem. Extensive investigations
ofthe occurrence ofmammary tumours in the
families of breast cancer patients were
started. A marked increase in breast cancer
was observed in the female relatives of
women with this tumour. The tumour
incidence is highest with sisters of a patient,
followed by mothers and aunts, and is less in
grandmothers and cousins. Accordingly, a
woman, whose mother or sister developed a
breast tumour, has approximately a two-fold
greater risk of also contracting this disease.
However, there has been no evidence thatthe
relatives of breast cancer patients have an
increased risk of cancer at other sites
(Wassink, 1935).
Familial factors in the genesis of a disease
are not necessarily genetic. The possibility
of environmental factors must also be
considered.
When the first inbred strains ofmice were
developed, it was found that there were
strains in which the females had a high
incidence of mammary tumours and others
which had no tumours. These strains were
suitable for the study ofthe genetic factors in
the genesis ofmammary tumours. In experi-
ments in which these inbred strains were
cross bred an unexpected discovery was
made. Only when the mother belonged to
the high cancer strain the Fl-hybrids had also
a high mammary tumour percentage whereas
when the mother belonged to the non-cancer
strain the offspring also had no tumours. It
had to be concluded, therefore, that an extra-
chromosomal factor determines the breast
tumour incidence. This factor is transmitted
from mother to offspring. A few years later
Bittner (1936) in his classic cross-suckling
experiments found that this factor is trans-
mitted with the mother's milk. Ifthe young
of a high cancer line are transferred immedi-
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ately after birth to a foster mother of the low
cancer line, the young do not develop breast
cancer.
Although in the beginning nothing was
known about this milk factor, the statisticians
took this finding as a lead for further investi-
gations into the human disease. Is there a
milk factor in humans too?
An indication against the existence of a
human milk factor" is that in populations
or social groups where breast feeding is least
practised, the highestratesofbreast cancerare
found. An even clearer indication against it
was that mammary tumour incidence was the
same among the paternal as among the
maternal grandmothers. This was also found
for paternal aunts compared withthematernal
ones. The conclusion of the statisticians,
therefore, was that there is no evidence for a
milk factor, causing human breast cancer
(Macklin, 1959).
One has to realize that one inbred strain is
comparable to only one individual, which is
replicated many times. Therefore it was
necessary to develop more inbred strains.
Several of these new strains developed in the
Netherlands Cancer Institute had ancestors-
as far as could be ascertained-that had no
relationship with American mice. Females
from one of these strains showed a very high
incidence of mammary tumours at an early
age. This strain called GR harbours a milk
factor but crosses with non-cancer strains
showed that this factor was not only trans-
mitted by the mother's milk but also with the
sperm of the father (Miihlbock, 1965). Con-
sequently it was also found that transmission
takes place with the ovum. In this strain
the mammary tumour agent is thus trans-
mitted at conception. The statisticians have
to take a fresh look at their pedigree charts in
view of the results with the GR-strain.
When the milk factor was discovered by
biological experiments nothing was known
about the nature of this agent. It is now
firmlyestablishedthatitisaRNA-virus. But
it took almost 20 years of laboratory work to
develop methods for its isolation and recogni-
tion. Biophysical procedures, such as density
gradient centrifugation andespecially electron
microscopic techniques, had to be perfected.
The development of these techniques had to
be combined with biological tests, which are
very time-consuming. The mouse mammary
tumour virion was studied in detail by
Bernhard, who called it the B-particle. The
mature virion has an eccentric electron-dense
nucleoid surrounded by a nucleoid membrane
and a large double membrane with spikes.
Some particles contain more than one nucle-
oid. The virus membrane can be broken up
by treatment with Tween-ether and the
nucleoid can then be isolated. The RNA
content is only 1% of the dry weight of the
virus particles. It is a 70S-ribonucleic acid
(Hageman et al., 1972).
B-particles mature at the membrane of
the cells in which they are formed. The
common budding places ofthe B-particles are
the microvilli of the mammary gland. Once
formed the virus particles are released into
vesicles in the cell or through the plasma
membrane, but preferably on the sides of the
cell adjacent to the lumen. Besides the
mammary gland there are also other sites in
the body where the reproduction of the virus
can take place, as could be shown in totally
mammectomized mice (Dux and Miihlbock,
1964).
Recently we have performed some experi-
ments by giving MTV from various strains
with the mother's milk to the same test
animals (Miiuhlbock and Dux, 1972). The
mammary tumour incidence in these foster
nursed strains varies from only a few mam-
mary tumours to 100% tumours. The
higher incidence is correlated with an earlier
average tumour age, i.e. the age at which the
first mammary tumour could be recognized.
From these and other observations it must
be concluded that each strain with a high
spontaneous rate of mammary tumours has
its own characteristic MTV that is different
from that ofother strains. There is as yet no
means, other than biological testing, to dis-
tinguish the MTV's individually. The mor-
phological picture does not show any dif-
ferences. It may be that when more refined
immunological methods have been worked
out differentiation of the MTVs from each
other will be possible.
It must thus be emphasized that we must
speak not of the mammary tumour virus but
of mammary tumour viruses.
There is still another variant of the mam-
mary tumour virus found in mice: NIV the
nodule inducing virus. This NIV is present
in certain mouse strains, usually in a low
concentration. It is also transmitted with
the genome at conception. This virus in-
duces nodules which are precancerous stages
in the mouse mammary gland, and it has a
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very low carcinogenic potential. A low
percentage of mammary tumours induced by
this virus appear very late in life.
One could ask how widespread is the MTV
in the known inbred strains of mice? The
question is difficult to answer. From the 243
strains registered, only in 45 are data about
the mammary tumour rate known. Only
every third strain from these 45 has a high
incidence of mammary tumours (14 from the
45); 31 have only a few mammary tumours.
One has, however, to take into account that
many inbred strains are related to each other.
Not all of these 45 strains have been tested
for the presence of MTV. The statement,
however, seems justified, that MTV is
demonstrable only in a minority of inbred
strains.
Another question is, what happens when
we give the mammarytumour virusartificially
to the strains which do not naturally harbour
this virus? It is difficult to generalize.
Usually the mammary tumour incidence is
elevated in the treated animals, but if these
treated animals are further bred the MTV
gets lost in the offspring. It is not possible to
convert the MTV-free strains into a strain
with a continuous high production of MTV
except in a few cases. Why the MTV dis-
appears in the offspring is unknown, but it is
certain that this disappearance is bound to a
certain genetic constitution.
There is some indication that in certain
mouse strains that were considered to be
virus-free a latent or hidden virus exists. As
Hageman, Calafat and Daams (1972) found,
the BALB/c strain is free of MTV in the first
halfofthe lifespan ofthe mouse, but at a later
age MTV can be demonstrated in the mam-
mary glands. It has to be assumed that the
release qf viral RNA is switched on at a later
age, but it is also possible that other mechan-
isms inhibit the production ofinfectious virus
particles at a younger age.
There is some indication that in some
strains considered MTV free, MTV is
"switched on "after treatment with x-rays or
with urethane (Boot et al., 1971). According
to Bentvelzen (1972) various experimental
data suggest that every mouse carries the
geneticinformationfor the productionofMTV.
The idea that cancer is a natural event
determined by spontaneous or induced de-
repression of specific viral oncogene has been
considered for some time. Lwoff (1960) has
proposed that the observation by Jacob and
Monod in the bacterial cell model system may
apply to the cancer problem. According to
this view, the expression of cancer virus
genes (operons), like other genes, would be
controlled by a system ofrepressors coded for
by regulator genes in the cell. Genetic
defects, mutations, inducing agents such as
radiation carcinogens and mutagens, finally
the ageing process itself lead to decreased
repression of the viral oncogene(s) (Huiibner
and Todaro, 1969). But mammary tumours
in mice are not caused by Hiibner's oncogene;
the viruses which are known to induce mam-
mary tumours are morphologically distinct
from the C-particles which are associated with
the oncogene.
Very soon after the discovery of MTV the
antigenicity of MTV to other species was
demonstrated clearly. The antigenicity of
MTV in its host species, the mouse, was
doubtful however until recently.
Precipitating antibodies to MTV-associ-
ated antigens have now been demonstrated.
One can distinguish antigens S1 and S2 from
the nucleoid and the antigen S3 from the
envelope. Theantigens S4 and S5 are not yet
correlated with a specific structure; they are
probably localized on the surface of the
virion.
The S1 antigen is the principal antigen of
the virion; it is group-specific which means
that it is the same in all mammary tumours in
different strains of mice. The viral antigens
are also found in the milk and in the tissue of
the normal mammary gland (Blair, 1972).
Specific antigens are also found in mam-
mary tumours, but they are very weak, incon-
stant and difficult to find. Purified B-par-
ticles arehighlyantigenic torabbits. Though
the virions are formed by budding from the
membrane of the mouse cell, they are also
antigenic to mice. Hilgers et al. (1971) found
antibodies both against internal and mem-
brane antigens of B-particles in several
strains of mice injected with virions.
Neonatally infected mice are at least
partially tolerant to the antigens of the virus
and to the virus-associated antigens in
infected cells.
Many attempts have been made to im-
munize MTV infected mice against mammary
tumours, but these experiments very often
resulted in acceleration of tumour growth
rather than its suppression.
The mammary tumour virus ofthe mouse
is thus being very extensively studied in
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every respect, and there can be no doubt that
this virus is instrumental in the induction of
mammary tumours in the mouse.
All efforts have failed so far to identify the
typical B-particle in another species other
than the mouse. The Mason-Pfizer virus,
which wNas found in the mammary tumour ofa
rhesus monkey, resembles type C-particles,
but it is morphologically different and its
oncogenicity has not yet been proven.
Considering the certainty of the role of
MTV in the genesis of mammary cancer in
mice, a search w-as made for the presence of
MTV in human beings (Dmochowski, Seman
and Gallagher, 1969; Feller and Chopra, 1971;
Sarkar and Moore, 1972).
The mammary tumour virus is abundant
in mammary tumours in certain strains of
mice. With this know%ledge at hand and the
methods available, breast cancer tissues from
wAomen have been investigated with the
electron microscope, and indeed a few
particles lhave been found which wNere similar
to the mouse virus. One must realize that
the search with an electron microscope can
cover only a very minute area of a tumour.
Unless there is a tremendous production of
virus particles in the cell, it is very unlikely
that one can find a virus.
From the mouse experiments it was known
that the milk contains the virus. Therefore,
a search has been made in human milk, wrhich
can be obtained in abundance.
The first results reported indeed showed
the presence ofparticles in human milk which
according to the electron microscopical
picture were assumed to be similar to the B-
particles in the mouse milk. Significantly
more particles were found in females from a
family with breast cancer history than in
females from families without a history of
breast cancer. But recent reports showed
fewer such particles and even no difference
between females with breast cancer in the
family and those wxithout a family history of
breast cancer. In our laboratory no intact
B-particles could be found in the milk of 43
Dutch women by means of the electron
microscope (Calafat and Hageman, 1973).
Since many cell membrane fragments can
assume shapes that are very similar to those
of certain viruses this discrepancy can prob-
ably be explained. The best evidence that
the particles in human milk are like B-
particles from the mouse has been given by
Sarkar and Moore (1972).
As it is extremely difficult to identify
virus particles with the electron microscope in
human breast cancer tissue or in milk, other
methods have to be developed. An im-
munological approach seems to be highly
promising. Antisera to purified human virus
particles may be used to see whether virus-
specific antigens are present in those tumours
or milk samples, in which no particles could
be detected. In view of our finding that the
mouse virus can replicate in other tissues than
the milk gland, it is worthwhile to look for the
presence of viral antigens in other human
tissues. In this way a correlation might be
found between tumour incidences in certain
families and the occurrence of such antigens.
In addition, it would be ofinterest to look
for a cross reaction between the mouse virus
and the human particles. Since it is at the
moment much easier to prepare antisera to
the mouse virus, the screening programme
outlined above could eventually be done with
these antisera to observe possible cross
reactions. There are indeed some indications
for common antigenicity of the mouse and
human particles.
In the past 2 years another approach for
the detection ofvirus in human milk has been
worked out, mainly by Schlom and Spiegel-
man (see Schlom et al., 1973).
The oncogenic RNA viruses, or oncorna
viruses, have 2 biochemical properties in
common which are unique for the whole
group. They possess a large single-stranded
RNA molecule with a sedimentation co-
efficient of 70S. They also contain
" reverse
transcriptase" an enzyme capable of using
the viral RNA as template to generate a DNA
complementary copy. The detection of both
these biochemical markers is called the
simultaneous detection test in milk.
Virus preparations are made from milk or
other biological fluids and purified by
gradient analysis. The 70S-RNA is in the
core of the virus, which can be isolated after
the outer membrane is dissolved. Under
certain experimental conditions, with tri-
tiated nucleotides added, tritiated DNA is
formed which sticks to the template. In the
gradient therefore this DNA is found in the
70S region. It represents a RNA-DNA
hybrid. Several hundred human milk
samples have been investigated with the
simultaneous detection test. Several investi-
gators found a very wide range of positive
samples.
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What does the positive simultaneous
detection test in human milk mean?
There are 2 interpretations: (1) it is a
reverse transcriptase containing RNA-virus;
(2) it is a non-viral, cell derived RNA-DNA
polymerase complex.
Unfortunately until now, no definite proof
is established that the particles found in the
milkwiththeelectron microscope areidentical
with the particles which are biochemically
characterized. Indeed, the correlation be-
tween the simultaneous detection test and the
test with the electron microscope has been
very poor. There are 2 factors which have to
be taken into consideration: (1) the sensi-
tivity difference. The electron microscope
methods needs 106 or 108 particles; the
simultaneous detection test is already positive
with 104 particles; (2) there are inhibitors in
the human milk of two kinds (a) one which
destroys the particle so that its morphology
is changed and (b) the reverse transcriptase
inhibitor, probably some enzymes in the milk
which interfere with the reverse transcriptase.
Many human milks (at least 25%) show
oncogenic RNA particles and have a positive
simultaneous detection test; the common
denominator is the reverse transcriptase
containing RNA virus.
The simultaneous detection test could
account for 4 viruses: (a) MTV Type B-
particles; (b) type C-particles; (c) foamy virus
and (d) Mason-Pfizer virus. All these viruses
may be found in the human population but
most of them are not disease-associated;
however, some members under certain cir-
cumstances may play a role and may even be
oncogenic.
70S RNAs of oncorna viruses have poly-
adenylic acid (poly (A)) regions, that repre-
sent approximately 1.5% ofthe viral genome.
According to Schlom et al. (1973) the 70S
RNA from human milk particles also con-
tains poly (A) stretches which are ofthe same
length (approximately 200 nucleotides long)
as those found in the mouse MTV. The
hybridization to poly (A) segments was used
as an assay for the detection and quantitation
of these particles in human milks and
quantitation of RNA tumour viruses in
biological fluids.
From 37 samples of human milk, 5 (14%)
were positive. That means that RNA
viruses in human beings and in mice both
have apoly (A)-stretch ofabout the same size.
Moreover, there are indications that they
share common sequences of nucleotides.
This can be concluded from the positive
results obtained in hybridization experiments
between mouse MTV/DNA and RNA from
human breast tumour tissue (Axel, Schlom
and Spiegelman, 1972).
All the experiments have given no definite
proof yet that a complete mammary tumour
virus is present in human beings.
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